NEWS RELEASE: MDC announces the acquisition of Lighteum, strengthening leadership in precision medical components manufacturing
San Diego — MDC (Medical Device Components), a leading global provider of high-precision, minimally invasive medical device components, today announced its acquisition of Lighteum, a pioneer in nitinol-based medical component manufacturing. The acquisition closed on Nov. 8, 2024.
This strategic acquisition brings together MDC’s long-standing expertise in platinum group metals and advanced micromachining with Lighteum’s cutting-edge capabilities in nitinol processing, which span high-throughput laser cutting, laser welding, heat shaping and electropolishing. The combination of these complementary technologies will enable MDC to further expand its portfolio and better serve the evolving needs of the medical device industry.
“We are excited to welcome Lighteum into the MDC family,” said Don Freeman, CEO of MDC. “By combining our capabilities, we will be able to offer our customers an unparalleled range of services, from prototyping through high-volume production. This acquisition demonstrates our commitment to continuous innovation and positions us to deliver more comprehensive solutions, improving patient outcomes worldwide.”
Adrien Sassi, partner at Montagu, commented: “We are thrilled to support MDC on this initial acquisition, following the successful carve-out of the business in July, and we warmly welcome the Lighteum team. Lighteum will enhance MDC’s front-end capabilities in design and development, helping companies innovate and accelerate the launch of life-saving medical devices.”
Lighteum, known for its rapid prototyping and transparent customer collaboration, has set itself apart as a nimble and flexible partner in the medical device industry. With the backing of MDC’s global infrastructure and extensive R&D and manufacturing resources, the combined company will be uniquely positioned to accelerate innovation, helping medical device companies bring their life-saving technologies to market faster and with even greater precision.
“This acquisition enables us to expand Lighteum’s white-glove customer service and quick-turn responsiveness to a global customer base,” said Lorie Lodico IV, COO of Lighteum. “The combination of MDC’s leadership in precious metal components and nitinol fabrication, with Lighteum’s expertise in nitinol process development, will push the boundaries of what’s possible in medical device manufacturing,” added Jose Maeso, CTO of Lighteum.
Together, MDC and Lighteum will continue to provide world-class customer support and ensure supply chain stability, expanding their manufacturing capabilities in San Diego, Mexicali, Australia and globally. By merging their strengths, the combined company will deliver cutting-edge solutions that meet the increasing complexity of medical device design.
The integration of Lighteum’s team and operations began immediately following the close of the acquisition.
About MDC
MDC is a global leader in the development and manufacture of precision medical components, specializing in platinum group metals, nitinol, and advanced coatings. With decades of expertise in metallurgy and micromachining, MDC serves the world’s leading medical device companies, helping them bring cutting-edge technologies to market with speed and reliability.
About Lighteum
Lighteum is a manufacturer of high-complexity nitinol-based medical components, focused on transforming customer experience through transparency and best-in-class innovation. Their core capabilities include femtosecond laser processing, heat shaping, and electropolishing technologies, serving the medical device market. Covington Associates served as exclusive financial advisor to Lighteum for this transaction.
About Montagu
Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focusing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specializes in carve-out and other first-time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process. Montagu partners with companies with enterprise values between €200 million and €1 billion and has €12bn assets under management. For additional information on Montagu, visit www.montagu.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
